Elicio Therapeutics, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
ELTX on Nasdaq
Industry
Pharmaceutical Preparations
Location
451 D Street, 5 Th Floor, Boston, MA

Insiders trading volume in the past year

Elicio Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Yekaterina Chudnovsky Director, 10%+ Owner $34M +$34M Nov 21, 2024
Eisa Abc Llc 10%+ Owner $15.9M Aug 31, 2021
Itzhak Goldberg Director $9.81M Jul 1, 2022
Jay Venkatesan Director $501K +$998K Nov 26, 2024
Gilbert S. Omenn Director $87.2K Jun 9, 2022
Victor F. Ganzi Director $87.2K Jun 9, 2022
Peter DeMuth Chief Scientific Officer $1.68K Dec 16, 2024
John F. Neylan Executive Vice President, Chief Medical Officer and Head of Research Mar 2, 2022
Jennifer J. Rhodes Executive Vice President, Chief Business Officer, General Counsel, Chief Compliance Officer and Secretary Mar 2, 2022
Gregory S. Curhan Chief Financial Officer Mar 2, 2022
Assaf Segal Director Jun 1, 2023
Robert Ruffolo Director Nov 21, 2024
Karen Wilson Director Nov 21, 2024
Christopher Haqq Title: Executive Vice President, Head of R&D and Chief Medical Officer Sep 30, 2024
Julian Adams Director Nov 21, 2024
Brian Piekos Chief Financial Officer Feb 1, 2024
Robert Connelly CEO, President and Director, Director Sep 30, 2024
Annette Matthies Chief Business Officer Jun 1, 2023
Carol Ashe Director Nov 21, 2024
Allen Nissenson Director Nov 21, 2024

Recent Insider Transactions by Companies or Individuals for Elicio Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.